This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Meritage Homes (MTH) Up 42% Over a Month: More Room to Run?
by Zacks Equity Research
Meritage Homes' (MTH) strategic shift to a pure-play entry-level and move-up builder is likely to drive growth.
April's Sales Rise Hints at Housing Comeback: Stocks in Focus
by Shrabana Mukherjee
New home sales edge higher in April with easing of lockdowns in the country. Is this an indication of revival in housing?
Housing Post COVID-19: All About Pricing, Volume & Rates
by Sanghamitra Saha
The homebuilding sector has suffered a lot amid COVID-19 and is likely to see meaningful sales and price decline ahead. However, credit conditions and valuations are cheaper.
Builders Confidence Up in May: Signs of Revival in Housing?
by Ankita Gupta
Builder sentiment rebounds in May with easing of lockdowns in the country. Is this an indication of revival in housing activity?
Homebuilder Confidence Rises in May: Is the Worst Over?
by Ritujay Ghosh
Mortgage applications for buying homes rose for four straight weeks, as the Fed pumped cash into the economy to lower mortgage rates as part of its efforts to stimulate economic activity.
Meritage Homes' (MTH) Shares Up as Q1 Earnings Top Estimates
by Zacks Equity Research
Meritage Homes' (MTH) first-quarter results reflect solid home closing revenues, gross margins and overhead leverage. However, coronavirus-induced shutdown weighs on the results.
March Housing Sales Drop Maximum Since 2015: More Pain Ahead?
by Ankita Gupta
Existing home sales decline in March as coronavirus hits the U.S. housing market. The worst reading is yet to come as most states are under stay-at-home orders.
PulteGroup (PHM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
PulteGroup's (PHM) Q1 results are likely to benefit from high demand for homes, buyouts & cost-saving actions. Lower ASPs, higher land/labor costs & shutdowns due to coronavirus may have been woes.
Order Cancellations Weigh on Housing ETFs: What Lies Ahead?
by Sanghamitra Saha
Big housing companies have been seeing order cancellations. However, still-open construction sites that add to the inventory and lower rates may perk up homebuying once the crisis is over.
Builder Confidence Nosedives in April Amid Coronavirus Scare
by Ankita Gupta
Builder sentiment falls to eight-year low as the coronavirus outbreak is restricting buyers to return to the marketplace.
The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy
Any Bright Spot in Q1 Earnings? Sector ETFs & Stocks to Buy
by Sweta Killa
First-quarter results are likely to be bleak, given that the coronavirus outbreak are weighing on corporate profits. However, there are still some bright spots. Let's have a look.
5 Stocks to Win Big This Brutal Q1 Earnings Season
by Tirthankar Chakraborty
There are certain sectors whose earnings are expected to perk up in the first quarter despite this pandemic. Such sectors include Construction, Medical, Consumer Staples and Utilities.
Why Meritage (MTH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Meritage (MTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
D.R. Horton's Q2 Sales Strong, March Cancellation Rate Rises
by Zacks Equity Research
Although D.R. Horton (DHI) reports strong Q2 orders, its March cancellation rate rises due to coronavirus pandemic.
Meritage Homes' (MTH) Q1 Orders Strong, March Orders Decline
by Zacks Equity Research
Although Meritage Homes (MTH) reports strong Q1 orders, its March orders decline due to coronavirus pandemic.
5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis
by Sumit Singh
Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.
The Zacks Analyst Blog Highlights: D.R. Horton, Meritage Homes, TRI Pointe, Century Communities and M.D.C.
by Zacks Equity Research
The Zacks Analyst Blog Highlights: D.R. Horton, Meritage Homes, TRI Pointe, Century Communities and M.D.C.
Coronavirus Risks Rife for Housing: What Does Spring Market Hold?
by Shrabana Mukherjee
The U.S. housing market is expected to be hurt by coronavirus-induced recession and layoffs. Will the ongoing spring season bring some relief?
Top Ranked Value Stocks to Buy for April 2nd
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 2nd
Are Investors Undervaluing Meritage Homes (MTH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
RPM's Q3 Results to be at Higher End of Previous Guidance
by Zacks Equity Research
RPM's third-quarter fiscal 2020 results are likely to be at the higher end of its prior view owing to strong restructuring initiatives.
Lennar (LEN) Earnings and Revenues Beat in Q1, Shares Rise
by Zacks Equity Research
Benefits from higher operating leverage and rising demand help Lennar (LEN) post better-than-expected fiscal Q1 earnings. However, it suspends guidance owing to the coronavirus crisis.
Housing Starts Drop in February, Coronavirus a Potent Threat
by Ankita Gupta
The housing space struggles to surge as COVID-19 disrupts world economy. Also, housing starts and building permits decline in March.
Builders Sentiments Slip in March as Coronavirus Fears Rise
by Zacks Equity Research
Builders sentiments slip two points low in March as coronavirus spreads across the United States.